特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
665999

眼内インプラントの世界市場:2018年~2022年

Global Ocular Implants Market 2018-2022

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 126 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.56円
眼内インプラントの世界市場:2018年~2022年
出版日: 2018年07月16日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 126 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

眼内インプラントについて

眼内インプラントは、損傷を受けた視覚器官または欠損している視覚器官を交換して、視力を回復させ、または外観を改善するように設計された医療装置です。義眼のような眼内インプラントは、目の疾患または外傷による顔の輪郭の損傷を改善するために使用する人工の眼です。

Technavioのアナリストは、2018年から2022年の間に、世界の眼内インプラント市場が12.52%のCAGRで成長すると予測しています。

当レポートでは、世界の眼内インプラント市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

第3章 調査方法

第4章 市場状況

  • 市場のエコシステム
  • 市場特性
  • 市場セグメンテーション分析

第5章 市場規模

  • 市場の定義
  • 市場規模(2017年)
  • 市場規模および予測(2017-2022年)

第6章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市場状況

第7章 市場セグメンテーション:製品別

  • セグメンテーション:製品別
  • 比較:製品別
  • IOL
  • 緑内障インプラント
  • 角膜インプラント
  • 義眼
  • 市場機会:製品別

第8章 顧客情勢

第9章 地域情勢

  • 地域別セグメンテーション(2017-2022年)
  • 地域比較
  • 南北アメリカ
  • 欧州・中東・アフリカ地域
  • アジア太平洋地域
  • 市場機会

第10章 意思決定の枠組み

第11章 成長要因と課題

  • 市場の成長要因
  • 市場の課題

第12章 市場動向

  • カスタムメイドの義眼
  • 眼科処置のための病院に対するASC選好の増加
  • 白内障手術のための医療観光の増加

第13章 ベンダー情勢

  • 概要
  • 創造的破壊の状況

第14章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Carl Zeiss Meditec
  • Johnson & Johnson
  • MORCHER
  • NIDEK
  • Novartis
  • Valeant Pharmaceuticals

第15章 付録

  • 略語のリスト
図表
  • Exhibit 01: Global ophthalmology devices market
  • Exhibit 02: Global ophthalmology devices market - Segmentation
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global ocular implants market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global ocular implants market - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Global ocular implants market by product - Market share 2017-2022 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Global IOLs market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Global IOLs market - Year-over-year growth 2018-2022 (%)
  • Exhibit 22: Global glaucoma implants market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Global glaucoma implants market - Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Global corneal implants market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 25: Global corneal implants market - Year-over-year growth 2018-2022 (%)
  • Exhibit 26: Global ocular prostheses market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 27: Global ocular prostheses market - Year-over-year growth 2018-2022 (%)
  • Exhibit 28: Market opportunity by product
  • Exhibit 29: Customer landscape
  • Exhibit 30: Global ocular implants market share by geography 2017-2022 (%)
  • Exhibit 31: Global ocular implants market - Regional comparison
  • Exhibit 32: Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 33: Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 34: Top 3 countries in Americas
  • Exhibit 35: EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 36: EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 37: Top 3 countries in EMEA
  • Exhibit 38: APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 39: APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 40: Top 3 countries in APAC
  • Exhibit 41: Market opportunity
  • Exhibit 42: Vendor landscape
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: Carl Zeiss Meditec - Overview
  • Exhibit 48: Carl Zeiss Meditec - Business segments
  • Exhibit 49: Carl Zeiss Meditec - Organizational developments
  • Exhibit 50: Carl Zeiss Meditec - Geographic focus
  • Exhibit 51: Carl Zeiss Meditec - Segment focus
  • Exhibit 52: Carl Zeiss Meditec - Key offerings
  • Exhibit 53: Carl Zeiss Meditec - Key customers
  • Exhibit 54: Johnson & Johnson - Overview
  • Exhibit 55: Johnson & Johnson - Business segments
  • Exhibit 56: Johnson & Johnson - Organizational developments
  • Exhibit 57: Johnson & Johnson - Geographic focus
  • Exhibit 58: Johnson & Johnson - Segment focus
  • Exhibit 59: Johnson & Johnson - Key offerings
  • Exhibit 60: Johnson & Johnson - Key customers
  • Exhibit 61: MORCHER - Overview
  • Exhibit 62: MORCHER - Product segments
  • Exhibit 63: MORCHER - Organizational developments
  • Exhibit 64: MORCHER - Geographic focus
  • Exhibit 65: MORCHER - Product segment focus
  • Exhibit 66: MORCHER - Key offerings
  • Exhibit 67: MORCHER - Key customers
  • Exhibit 68: NIDEK - Overview
  • Exhibit 69: NIDEK - Product segments
  • Exhibit 70: NIDEK - Organizational developments
  • Exhibit 71: NIDEK - Geographic focus
  • Exhibit 72: NIDEK - Product segment focus
  • Exhibit 73: NIDEK - Key offerings
  • Exhibit 74: NIDEK - Key customers
  • Exhibit 75: Novartis - Overview
  • Exhibit 76: Novartis - Business segments
  • Exhibit 77: Novartis - Organizational developments
  • Exhibit 78: Novartis - Geographic focus
  • Exhibit 79: Novartis - Segment focus
  • Exhibit 80: Novartis - Key offerings
  • Exhibit 81: Novartis - Key customers
  • Exhibit 82: Valeant Pharmaceuticals - Overview
  • Exhibit 83: Valeant Pharmaceuticals - Business segments
  • Exhibit 84: Valeant Pharmaceuticals - Organizational developments
  • Exhibit 85: Valeant Pharmaceuticals - Geographic focus
  • Exhibit 86: Valeant Pharmaceuticals - Segment focus
  • Exhibit 87: Valeant - Key offerings
  • Exhibit 88: Valeant Pharmaceuticals - Key customers
目次
Product Code: IRTNTR22467

About Ocular Implants

Ocular implants are medical devices designed to replace a damaged or missing visual organ to restore vision or to improve visual appearance. Ocular implants such as ocular prostheses are artificial eyes used by people to improve facial lineaments damages due to an eye disease or trauma.

Technavio's analysts forecast the global ocular implants market to grow at a CAGR of 12.52% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global ocular implants market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of IOLs, corneal implants, glaucoma implants, and ocular prostheses.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Ocular Implants Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Carl Zeiss Meditec
  • Johnson & Johnson
  • MORCHER
  • NIDEK
  • Novartis
  • Valeant Pharmaceuticals

Market driver

  • Increasing access to ocular implants in emerging markets
  • For a full, detailed list, view our report

Market challenge

  • Limited reimbursements for ocular implants
  • For a full, detailed list, view our report

Market trend

  • Increasing medical tourism for cataract surgery
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • IOLs
  • Glaucoma implants
  • Corneal implants
  • Ocular prostheses
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Custom-made ocular prostheses
  • Increasing preference for ASCs over hospitals for ophthalmology procedures
  • Increasing medical tourism for cataract surgery

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Carl Zeiss Meditec
  • Johnson & Johnson
  • MORCHER
  • NIDEK
  • Novartis
  • Valeant Pharmaceuticals

PART 15: APPENDIX

  • List of abbreviations
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.